Department of Anesthesiology, the First Affiliated Hospital, Wenzhou Medical College, 2 Fuxue Rd., Wenzhou City, Zhejiang Province, China 325000.
Anesth Analg. 2013 Aug;117(2):507-13. doi: 10.1213/ANE.0b013e318297fcee. Epub 2013 Jun 6.
The transversus abdominis plane (TAP) block has been shown to provide effective postoperative analgesia in lower abdominal surgery. Subcostal TAP block has also been proposed as a new technique to provide analgesia for the supraumbilical abdomen. We compared the analgesic and opioid-sparing effects of a single-injection subcostal TAP block with continuous thoracic epidural analgesia and IV opioid analgesia.
Ninety patients undergoing elective radical gastrectomy were randomized to receive either combined general-subcostal TAP anesthesia (group TAP), combined general-epidural anesthesia (group EA), or general anesthesia (group GA), and were analyzed on an intention-to-treat basis. In group TAP, a bilateral subcostal TAP block was performed after induction of general anesthesia using 20 mL of 0.375% ropivacaine. In group EA, a thoracic epidural was placed between T8 and T9 and bolused with 8 mL of 0.25% ropivacaine before induction of general anesthesia. The epidural was maintained with 5 mL/h of 0.25% ropivacaine during the surgery. Group GA received standard general anesthesia. In the postanesthesia care unit (PACU), all groups received IV morphine titration for visual analog scale (VAS) pain scores >3. All patients were started on IV patient-controlled analgesia with morphine after morphine titration in the PACU, while group EA also had their epidural maintained with 5 mL/h of 0.125% bupivacaine with 8 μg/mL morphine. Patients were assessed in the PACU and at 1, 3, 6, 24, 48, and 72 hours postoperatively. Primary outcomes measured were morphine consumption at 24 hours and all VAS pain scores.
Data from 82 of 90 (91.1%) patients were included in the study. Group TAP demonstrated decreased cumulative morphine consumption at 24 hours (98.75% confidence intervals, -29 to -9 mg) and noninferiority on VAS pain scores at all measurement times, as compared with group GA with standard opioid analgesia. However, group EA was superior to group TAP regarding cumulative morphine consumption at 24 hours (98.75% confidence intervals, -23 to -4 mg) and noninferior to group TAP on VAS pain scores at all comparison points. Group TAP had reduced morphine consumption from PACU admission to 6 hours as compared with group GA, but increased morphine consumption for 6 to 24 hours as compared with group EA.
Single-injection subcostal TAP block was more effective than IV opioid analgesia, while continuous thoracic epidural analgesia was more effective than the single-injection subcostal TAP block.
腹横肌平面(TAP)阻滞已被证明可有效缓解下腹部手术的术后疼痛。肋缘下 TAP 阻滞也被提出作为一种为上腹部提供镇痛的新技术。我们比较了单次肋缘下 TAP 阻滞与连续胸椎硬膜外镇痛和 IV 阿片类药物镇痛的镇痛和阿片类药物节约效果。
90 例行择期根治性胃切除术的患者随机分为接受联合全身-肋缘下 TAP 麻醉(TAP 组)、联合全身-硬膜外麻醉(EA 组)或全身麻醉(GA 组),并进行意向治疗分析。在 TAP 组中,在全身麻醉诱导后使用 20 mL 0.375%罗哌卡因进行双侧肋缘下 TAP 阻滞。在 EA 组中,在 T8 和 T9 之间放置胸椎硬膜外腔,并在全身麻醉诱导前推注 8 mL 0.25%罗哌卡因。手术期间硬膜外腔以 5 mL/h 的 0.25%罗哌卡因维持。GA 组接受标准全身麻醉。在麻醉后恢复室(PACU)中,所有组均接受 IV 吗啡滴定以缓解视觉模拟量表(VAS)疼痛评分>3。所有患者在 PACU 中进行吗啡滴定后开始接受 IV 患者自控镇痛,给予吗啡,同时 EA 组还将硬膜外腔以 5 mL/h 的 0.125%布比卡因和 8 μg/mL 吗啡维持。患者在 PACU 和术后 1、3、6、24、48 和 72 小时进行评估。主要观察指标为 24 小时内吗啡消耗量和所有 VAS 疼痛评分。
90 例患者中的 82 例(91.1%)的数据纳入研究。与接受标准阿片类药物镇痛的 GA 组相比,TAP 组在 24 小时内累积吗啡消耗量减少(98.75%置信区间,-29 至-9 mg),且在所有测量时间的 VAS 疼痛评分均具有非劣效性。然而,EA 组在 24 小时内累积吗啡消耗量(98.75%置信区间,-23 至-4 mg)优于 TAP 组,且在所有比较点的 VAS 疼痛评分均与 TAP 组非劣效。与 GA 组相比,TAP 组从 PACU 入院到 6 小时吗啡消耗量减少,但与 EA 组相比,6 至 24 小时吗啡消耗量增加。
单次肋缘下 TAP 阻滞比 IV 阿片类药物镇痛更有效,而连续胸椎硬膜外镇痛比单次肋缘下 TAP 阻滞更有效。